• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

梯度高效液相色谱法测定甲磺酸阿地唑仑缓释片制剂中的降解产物

Gradient high performance liquid chromatographic assay for degradation products of adinazolam mesylate in a sustained release tablet formulation.

作者信息

Stemm N L, Skoug J W, Robins R H

机构信息

Upjohn Laboratories, Upjohn Company, Kalamazoo, Michigan 49001, USA.

出版信息

Pharm Res. 1995 May;12(5):738-45. doi: 10.1023/a:1016219927912.

DOI:10.1023/a:1016219927912
PMID:7479561
Abstract

A gradient high performance liquid chromatographic method was developed to determine degradation products of adinazolam mesylate in a sustained release tablet formulation. Sample preparations were chromatographed on a YMC-Basic column using a formate buffer/acetonitrile gradient with absorbance detection at 254 nm. Adinazolam mesylate was found to degrade at high relative humidity and temperature to form a major product, the 6-aminoquinoline analog, plus numerous other compounds. Five of these compounds were identified and their structures indicate that the solid-state degradation of adinazolam, in the presence of sufficient moisture, involves not only a hydrolytic mechanism, but also an oxidative mechanism. Potential process impurities were resolved from the drug and degradation products. Recovery was near 100% over the 0.5 to 10% range for the major degradate (6-aminoquinoline) and over the 0.5 to 1% range for the other analytes. The method was applied to tablet samples stressed at high relative humidity and temperature. The relative standard deviation of the assay for the 6-aminoquinoline was less than 2% and less than 13% for the minor components. Calculated mass balances (sum of adinazolam plus degradation products in the degraded tablet divided by the same sum in the undegraded tablet) were less than 100% and were dependent on the extent of degradation in the tablet. The average mass balance result obtained for samples that were an average of 9.5% degraded was 95.0 +/- 1.5%. It is possible that the decrease in mass balance with increase in percent degradation may be explained by the formation of many components at trace levels due to degradation by various permutations of hydrolytic and oxidative reaction pathways.

摘要

建立了一种梯度高效液相色谱法,用于测定甲磺酸阿地唑仑缓释片制剂中的降解产物。样品制备后在YMC - Basic柱上进行色谱分析,采用甲酸盐缓冲液/乙腈梯度洗脱,在254 nm处进行吸光度检测。发现甲磺酸阿地唑仑在高相对湿度和温度下会降解,形成一种主要产物,即6 - 氨基喹啉类似物,以及许多其他化合物。鉴定出其中5种化合物,其结构表明在有足够水分存在的情况下,阿地唑仑的固态降解不仅涉及水解机制,还涉及氧化机制。潜在的工艺杂质与药物及降解产物得以分离。主要降解产物(6 - 氨基喹啉)在0.5%至10%范围内的回收率接近100%,其他分析物在0.5%至1%范围内的回收率接近100%。该方法应用于在高相对湿度和温度下加速试验的片剂样品。6 - 氨基喹啉含量测定的相对标准偏差小于2%,次要成分的相对标准偏差小于13%。计算得到的质量平衡(降解片剂中甲磺酸阿地唑仑与降解产物的总和除以未降解片剂中相同总和)小于100%,且取决于片剂中的降解程度。对于平均降解率为9.5%的样品,获得的平均质量平衡结果为95.0 +/- 1.5%。质量平衡随降解百分比增加而降低,可能是由于水解和氧化反应途径的各种排列组合导致降解产生许多痕量成分所致。

相似文献

1
Gradient high performance liquid chromatographic assay for degradation products of adinazolam mesylate in a sustained release tablet formulation.梯度高效液相色谱法测定甲磺酸阿地唑仑缓释片制剂中的降解产物
Pharm Res. 1995 May;12(5):738-45. doi: 10.1023/a:1016219927912.
2
Pharmacokinetics and pharmacodynamics of adinazolam and N-desmethyladinazolam after oral and intravenous dosing in healthy young and elderly volunteers.阿地唑仑和N-去甲基阿地唑仑在健康青年和老年志愿者口服及静脉给药后的药代动力学和药效学
J Clin Psychopharmacol. 1992 Dec;12(6):403-14.
3
Pharmacokinetic and pharmacodynamic comparison of immediate-release and sustained-release adinazolam mesylate tablets after single- and multiple-dose administration.
Pharm Res. 1992 Apr;9(4):457-63. doi: 10.1023/a:1015875910222.
4
Effect of food on the bioavailability of adinazolam from a sustained release formulation: effect of meal timing and lack of dose dumping.
Biopharm Drug Dispos. 1990 Nov;11(8):715-27. doi: 10.1002/bdd.2510110807.
5
Psychomotor and memory effects of two adinazolam formulations assessed by a computerized neuropsychological test battery.通过计算机化神经心理测试组合评估两种阿地唑仑制剂的精神运动和记忆效应。
J Clin Pharmacol. 1993 May;33(5):463-9. doi: 10.1002/j.1552-4604.1993.tb04689.x.
6
The lack of effect of smoking on the pharmacokinetics and pharmacodynamics of adinazolam and N-demethyladinazolam.吸烟对阿地唑仑和N-去甲基阿地唑仑的药代动力学及药效学无影响。
Biopharm Drug Dispos. 1994 May;15(4):263-72. doi: 10.1002/bdd.2510150402.
7
Diffusion in HPMC gels. II. Prediction of drug release rates from hydrophilic matrix extended-release dosage forms.羟丙基甲基纤维素凝胶中的扩散。II. 亲水性基质缓释剂型药物释放速率的预测。
Pharm Res. 1995 Jul;12(7):965-71. doi: 10.1023/a:1016246028338.
8
Stability-indicating UHPLC method for determination of nevirapine in its bulk form and tablets: identification of impurities and degradation kinetic study.用于测定奈韦拉平原料药及其片剂的稳定性指示超高效液相色谱法:杂质鉴定与降解动力学研究
J Pharm Biomed Anal. 2016 Jul 15;126:103-8. doi: 10.1016/j.jpba.2016.05.005. Epub 2016 May 3.
9
UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.超高效液相色谱法(UPLC)和液相色谱 - 质谱联用(LC - MS)对盐酸伊立替康降解行为的研究以及开发一种经验证的稳定性指示超高效液相色谱法,用于测定药物剂型中盐酸伊立替康及其杂质。
J Chromatogr Sci. 2012 Oct;50(9):810-9. doi: 10.1093/chromsci/bms075. Epub 2012 Jun 1.
10
Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation.用于同时测定药物制剂中甲磺酸雷沙吉兰工艺相关杂质和降解产物的稳定性指示反相高效液相色谱法的开发与验证
J Chromatogr Sci. 2013 Mar;51(3):242-9. doi: 10.1093/chromsci/bms134. Epub 2012 Sep 17.

本文引用的文献

1
Assay of adinazolam in plasma by liquid chromatography.采用液相色谱法测定血浆中阿地唑仑的含量。
J Pharm Sci. 1984 Aug;73(8):1173-5. doi: 10.1002/jps.2600730840.
2
Kinetics and equilibrium of the reversible alprazolam ring-opening reaction.
J Pharm Sci. 1983 Apr;72(4):356-62. doi: 10.1002/jps.2600720409.
3
[Analysis and stability of various pharmaceutically interesting benzodiazepines. 1. Diazepam and nitrazepam, course of hydrolysis and determination of a circle contraction to isomeric quinolone derivatives].[多种具有药学意义的苯二氮䓬类药物的分析与稳定性。1. 地西泮和硝西泮,水解过程及向异构喹诺酮衍生物的环收缩测定]
Pharmazie. 1972 Jan;27(1):32-42.
4
Collection of analytical data for benzodiazepines and benzophenones.苯二氮卓类和二苯甲酮类分析数据的收集。
J Chromatogr. 1988 May 20;439(2):317-39. doi: 10.1016/s0021-9673(01)83844-9.
5
High-performance liquid chromatographic assay of adinazolam and its desmethyl metabolite.
J Chromatogr. 1988 Jan 22;424(1):215-7. doi: 10.1016/s0378-4347(00)81098-1.
6
Biopharmacological data and high-performance liquid chromatographic analysis of 1,4-benzodiazepines in biological fluids: a review.生物流体中1,4-苯二氮䓬类药物的生物药理学数据及高效液相色谱分析:综述
J Pharm Biomed Anal. 1992 Feb-Mar;10(2-3):109-36. doi: 10.1016/0731-7085(92)80019-j.